Tarsus Pharmaceuticals, Inc. TARS Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s free cash flow margin?
- Tarsus Pharmaceuticals, Inc. (TARS) reported free cash flow margin of -28% in Q2 2025.
- How has Tarsus Pharmaceuticals, Inc.'s free cash flow margin changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s free cash flow margin increased by 81.4% year-over-year, from -150.5% to -28%.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s free cash flow margin?
- Over 2 years (2022 to 2024), Tarsus Pharmaceuticals, Inc.'s free cash flow margin has grown at a -50.9% compound annual growth rate (CAGR), from -191.9% to -46.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.